´ëÇѳúÁ¹ÁßÇÐȸ 3¿ù º¸¼ö±³À° : 2024-03-23
±³À°ÀÏÀÚ : 2024-03-23
±³À°Àå¼Ò : ¼¼Á¾´ëÇб³ ´ë¾çAIȦ
±³À°ÁÖÁ¦ : (¿Â-¿ÀÇÁº´Çà) ´ëÇѳúÁ¹ÁßÇÐȸ 3¿ù º¸¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѳúÁ¹ÁßÇÐȸ
´ã´çÀÚ : ±èÈñ¿µ
¿¬¶ôó : 0502-277-1919
À̸ÞÀÏ : stroke@stroke.or.kr
±³À°Á¾·ù : ½Å°æ¿Ü°ú, ¿µ»óÀÇÇаú, ½Å°æ°ú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 45ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í *»çÀüµî·Ï: Á¤È¸¿ø 2¸¸¿ø/ ÁØȸ¿ø, ÀϹÝȸ¿ø 1¸¸¿ø/ Á¤È¸¿ø Áß È¸ºñ¹Ì³³È¸¿ø 5¸¸¿ø/ ºñȸ¿ø Àü°øÀÇ, °£È£»ç, ¿¬±¸¿ø 3¸¸¿ø/ ºñȸ¿ø Àü¹®ÀÇ 5¸¸¿ø *ÇöÀåµî·Ï: Á¤È¸¿ø 4¸¸¿ø/ ÁØȸ¿ø, ÀϹÝȸ¿ø 2¸¸¿ø/ Á¤È¸¿ø Áß È¸ºñ¹Ì³³È¸¿ø 6¸¸¿ø/ ºñȸ¿ø Àü°øÀÇ, °£È£»ç, ¿¬±¸¿ø 4¸¸¿ø/ ºñȸ¿ø Àü¹®ÀÇ 6¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 09:00~09:25 Localization in stroke and stroke syndromes Á¤¿äÇÑ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 09:25~09:50 Assessment of stroke severity and functional outcome ±è¿¹¸²(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 09:50~10:15 Stroke etiology and workup for acute ischemic stroke ±èÁø±Ç(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 10:15~10:40 Interpretation of imaging studies for stroke ÇãÁسç(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 10:40~11:05 Neurological assessment and menagement in patients with decreased consciousness ±èÅÂÁ¤(¼¿ïÀÇ´ë)
ÈÞ½Ä 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 11:05~11:20 Break ()
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 11:20~11:45 Hyperacute stroke management ¹éÀåÇö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 11:45~12:10 Practical use of antiplatelet therapy ¿À¹Ì¼±(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 12:10~12:35 Practical use of anticoagulant therapy ±è¹üÁØ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 03¿ù 23ÀÏ ¼¼Á¾´ëÇб³ ´ë¾çAIȦ 12:35~13:00 Practical use of lipid-lowering agents ±è¹üÁØ(¼¿ïÀÇ´ë)